SEAN SMITHSON: Open Payments
NPI 1467133348 · WESTMINSTER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$247 in 12 payments from 9 companies in 2025. Trend: 2023 $17 · 2024 $129 · 2025 $247
Food & beverage: $247
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $67 |
| Sumitomo Pharma America, Inc. | 2 | $40 |
| Exact Sciences Corporation | 1 | $30 |
| ABBVIE INC. | 1 | $26 |
| Lilly USA, LLC | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
Products named: GEMTESA, Cologuard Collection Kit, Rybelsus, UBRELVY, MOUNJARO, Wegovy, FARXIGA, Ozempic.
Industry payments across MD — which companies pay providers there.
